ArticleClinical ophthalmology (Auckland, N.Z.)2024

Efficacy and Safety of an Indian Bevacizumab BIOSimilar (BEVATAS) for Retinal Vein Occlusion (BIOS-RVO Study).

Somnath Chakraborty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.